ATE517094T1 - Verfahren zur herstellung von medetomidin und seinen salzen - Google Patents
Verfahren zur herstellung von medetomidin und seinen salzenInfo
- Publication number
- ATE517094T1 ATE517094T1 AT07822154T AT07822154T ATE517094T1 AT E517094 T1 ATE517094 T1 AT E517094T1 AT 07822154 T AT07822154 T AT 07822154T AT 07822154 T AT07822154 T AT 07822154T AT E517094 T1 ATE517094 T1 AT E517094T1
- Authority
- AT
- Austria
- Prior art keywords
- salts
- medetomidine
- producing
- transmetalation
- dimethylbenzaldehyde
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06123548A EP1918282A1 (de) | 2006-11-06 | 2006-11-06 | Verfahren zur Herstellung von Medetomidine und ihre Salzen |
| PCT/EP2007/061822 WO2008055852A1 (en) | 2006-11-06 | 2007-11-02 | Method for preparing medetomidine and its salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE517094T1 true ATE517094T1 (de) | 2011-08-15 |
Family
ID=37770375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07822154T ATE517094T1 (de) | 2006-11-06 | 2007-11-02 | Verfahren zur herstellung von medetomidin und seinen salzen |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7902377B2 (de) |
| EP (2) | EP1918282A1 (de) |
| JP (1) | JP2010508332A (de) |
| KR (1) | KR20090052398A (de) |
| CN (1) | CN101535272B (de) |
| AT (1) | ATE517094T1 (de) |
| AU (1) | AU2007316693B2 (de) |
| BR (1) | BRPI0714992A2 (de) |
| CA (1) | CA2660365C (de) |
| DK (1) | DK2079706T3 (de) |
| EA (1) | EA200900355A1 (de) |
| ES (1) | ES2369746T3 (de) |
| MX (1) | MX2009004649A (de) |
| NZ (1) | NZ575125A (de) |
| PL (1) | PL2079706T3 (de) |
| PT (1) | PT2079706E (de) |
| SI (1) | SI2079706T1 (de) |
| WO (1) | WO2008055852A1 (de) |
| ZA (1) | ZA200902607B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102753532B (zh) * | 2009-12-09 | 2015-05-13 | I-技术有限公司 | 美托咪定的制备方法 |
| CN102452984B (zh) * | 2010-10-21 | 2013-10-23 | 桑迪亚医药技术（上海）有限责任公司 | 4-[1-(2,3-二甲基苯基)乙烯基]-1-r1-2-r2咪唑的合成方法 |
| IN2014DN00144A (de) | 2011-07-22 | 2015-05-22 | Cambrex Karlskoga Ab | |
| WO2012172119A2 (en) | 2012-05-08 | 2012-12-20 | Lonza Ltd | Method for the preparation of medetomidine |
| JP5777840B2 (ja) * | 2012-05-08 | 2015-09-09 | ロンザ・リミテッド | ２−（２，３−ジメチルフェニル）−１−プロパナールを調製するための方法 |
| IN2014DN07983A (de) * | 2012-05-08 | 2015-05-01 | Lonza Ag | |
| IN2014DN08121A (de) | 2012-06-28 | 2015-05-01 | Lonza Ag | |
| WO2012172121A1 (en) * | 2012-06-28 | 2012-12-20 | Lonza Ltd | Method for the preparation of medetomidine with chloroacetone |
| US9156793B2 (en) * | 2012-06-28 | 2015-10-13 | Lonza Ltd. | Method for preparation of medetomidine with chloroacetone |
| WO2012172122A2 (en) | 2012-06-28 | 2012-12-20 | Lonza Ltd | Method for the preparation of 2-(2,3-dimethylphenyl)-1-propanal |
| CN103588711B (zh) | 2013-11-27 | 2015-04-08 | 天津炜捷制药有限公司 | 一种美托咪定中间体的制备方法 |
| CN103664788B (zh) * | 2013-12-04 | 2015-11-25 | 湖北生物医药产业技术研究院有限公司 | 制备美托咪啶的方法 |
| CN104447562A (zh) * | 2014-03-27 | 2015-03-25 | 宁波天衡药业股份有限公司 | 一种制备盐酸右美托咪定关键中间体的新方法 |
| CN106083724B (zh) * | 2016-08-02 | 2018-06-26 | 江苏恒瑞医药股份有限公司 | 一种右美托咪定的制备方法 |
| CN111269192A (zh) * | 2020-02-25 | 2020-06-12 | 成都睿智化学研究有限公司 | 一种5-羟甲基四氮唑及其衍生物的合成方法 |
| CN114671811A (zh) * | 2022-04-14 | 2022-06-28 | 南京正科医药股份有限公司 | 一种右美托咪定拆分副产物的外消旋化回收方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2069481B (en) | 1980-02-13 | 1983-07-27 | Farmos Oy | Substituted imidazole derivatives |
| GB2101114B (en) * | 1981-07-10 | 1985-05-22 | Farmos Group Ltd | Substituted imidazole derivatives and their preparation and use |
| WO2006036497A2 (en) * | 2004-09-24 | 2006-04-06 | Allergan, Inc. | 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| WO2006036480A1 (en) * | 2004-09-24 | 2006-04-06 | Allergan, Inc. | 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists |
-
2006
- 2006-11-06 EP EP06123548A patent/EP1918282A1/de not_active Withdrawn
-
2007
- 2007-11-02 BR BRPI0714992-1A patent/BRPI0714992A2/pt not_active IP Right Cessation
- 2007-11-02 CA CA2660365A patent/CA2660365C/en active Active
- 2007-11-02 DK DK07822154.6T patent/DK2079706T3/da active
- 2007-11-02 MX MX2009004649A patent/MX2009004649A/es not_active Application Discontinuation
- 2007-11-02 SI SI200730737T patent/SI2079706T1/sl unknown
- 2007-11-02 AT AT07822154T patent/ATE517094T1/de active
- 2007-11-02 CN CN2007800358734A patent/CN101535272B/zh not_active Expired - Fee Related
- 2007-11-02 WO PCT/EP2007/061822 patent/WO2008055852A1/en not_active Ceased
- 2007-11-02 NZ NZ575125A patent/NZ575125A/en not_active IP Right Cessation
- 2007-11-02 PT PT07822154T patent/PT2079706E/pt unknown
- 2007-11-02 JP JP2009535083A patent/JP2010508332A/ja active Pending
- 2007-11-02 PL PL07822154T patent/PL2079706T3/pl unknown
- 2007-11-02 ES ES07822154T patent/ES2369746T3/es active Active
- 2007-11-02 KR KR1020097007913A patent/KR20090052398A/ko not_active Ceased
- 2007-11-02 EP EP07822154A patent/EP2079706B1/de active Active
- 2007-11-02 EA EA200900355A patent/EA200900355A1/ru unknown
- 2007-11-02 US US12/312,324 patent/US7902377B2/en active Active
- 2007-11-02 AU AU2007316693A patent/AU2007316693B2/en not_active Ceased
-
2009
- 2009-04-16 ZA ZA200902607A patent/ZA200902607B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008055852A8 (en) | 2009-05-22 |
| CA2660365C (en) | 2014-03-25 |
| BRPI0714992A2 (pt) | 2013-07-30 |
| EA200900355A1 (ru) | 2009-10-30 |
| KR20090052398A (ko) | 2009-05-25 |
| AU2007316693B2 (en) | 2012-02-02 |
| CN101535272A (zh) | 2009-09-16 |
| EP2079706A1 (de) | 2009-07-22 |
| ES2369746T3 (es) | 2011-12-05 |
| DK2079706T3 (da) | 2011-10-03 |
| US20100048915A1 (en) | 2010-02-25 |
| EP1918282A1 (de) | 2008-05-07 |
| ZA200902607B (en) | 2010-04-28 |
| CN101535272B (zh) | 2011-10-05 |
| CA2660365A1 (en) | 2008-05-15 |
| PT2079706E (pt) | 2011-10-19 |
| MX2009004649A (es) | 2009-05-21 |
| JP2010508332A (ja) | 2010-03-18 |
| US7902377B2 (en) | 2011-03-08 |
| AU2007316693A1 (en) | 2008-05-15 |
| PL2079706T3 (pl) | 2011-12-30 |
| SI2079706T1 (sl) | 2011-11-30 |
| NZ575125A (en) | 2011-02-25 |
| WO2008055852A1 (en) | 2008-05-15 |
| EP2079706B1 (de) | 2011-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900355A1 (ru) | Способ получения медетомидина и его солей | |
| IL214183A (en) | Pharma-informatics system and method, preparation for use with it and method for preparation of the preparation | |
| DE602004020538D1 (de) | Verfahren und Vorrichtung zur Laserbestrahlung, sowie Verfahren zur Herstellung von Halbleiter. | |
| AT9435U3 (de) | Kopierfräseinrichtung zur herstellung von insbesondere zahntechnischen werkstücken | |
| ATE542803T1 (de) | Verfahren zur herstellung von dihydrochinazolinen | |
| DE502006000218D1 (de) | Verfahren zur Herstellung von SiOC-verknüpften, linearen Polydialkylsiloxan-Polyoxyalkylen-Blockcopolymeren | |
| SG166091A1 (en) | Method for producing isocyanates | |
| DE502004009142D1 (de) | Verfahren zur herstellung substituierter 3-aryl-butyl-aminverbindungen | |
| MX2007001035A (es) | Metodo para producir una composicion, la composicion y su uso. | |
| IL185031A0 (en) | Method for the preparation of pregabalin and salts thereof | |
| ATE482966T1 (de) | Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide | |
| ATE449096T1 (de) | Verfahren zur herstellung von 3(r)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-p enoxypropyl)-1- azoniabicycloä2.2.2üoctanbromid | |
| EA201070689A1 (ru) | Композиция для личного ухода | |
| DE602005015174D1 (de) | Verfahren zur herstellung von montelukast-natrium | |
| WO2008085900A3 (en) | Methods for generating novel stabilized proteins | |
| PL1928836T3 (pl) | Podstawione 4-fenylotetrahydroizochinoliny, sposób ich wytwarzania, zastosowanie jako lek oraz lek je zawierający | |
| DE602006017480D1 (de) | Oxidkomplexlaminat, Verfahren zur Herstellung eines Oxidkomplexlaminats und Vorrichtung | |
| ATE516290T1 (de) | Verfahren zur herstellung von buprenorphin und derivaten von buprenorphin | |
| ATE376997T1 (de) | Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten | |
| TW200833751A (en) | Method for preparing polyester nanocomposites | |
| DE602004004677D1 (de) | Verfahren zur herstellung substituierter 5-amino-pyrazolo-ä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine | |
| TW200619205A (en) | A method for preparing irbesartan and intermediates thereof | |
| WO2010148177A3 (en) | Compounds, compositions, methods of synthesis, and methods of treatment | |
| DE602005021110D1 (de) | Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten | |
| DE502005007702D1 (de) | Verfahren zur herstellung von terrylen-3,4:11,12-t |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2079706 Country of ref document: EP |